155 related articles for article (PubMed ID: 20034026)
1. Inhibition of poly adenosine diphosphate-ribose polymerase decreases hepatocellular carcinoma growth by modulation of tumor-related gene expression.
Quiles-Perez R; Muñoz-Gámez JA; Ruiz-Extremera A; O'Valle F; Sanjuán-Nuñez L; Martín-Alvarez AB; Martín-Oliva D; Caballero T; Muñoz de Rueda P; León J; Gonzalez R; Muntané J; Oliver FJ; Salmerón J
Hepatology; 2010 Jan; 51(1):255-66. PubMed ID: 20034026
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis.
Martin-Oliva D; Aguilar-Quesada R; O'valle F; Muñoz-Gámez JA; Martínez-Romero R; García Del Moral R; Ruiz de Almodóvar JM; Villuendas R; Piris MA; Oliver FJ
Cancer Res; 2006 Jun; 66(11):5744-56. PubMed ID: 16740713
[TBL] [Abstract][Full Text] [Related]
3. Synergistic cytotoxicity of the poly (ADP-ribose) polymerase inhibitor ABT-888 and temozolomide in dual-drug targeted magnetic nanoparticles.
Muñoz-Gámez JA; López Viota J; Barrientos A; Carazo Á; Sanjuán-Nuñez L; Quiles-Perez R; Muñoz-de-Rueda P; Delgado Á; Ruiz-Extremera Á; Salmerón J
Liver Int; 2015 Apr; 35(4):1430-41. PubMed ID: 24821649
[TBL] [Abstract][Full Text] [Related]
4. Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis.
Tentori L; Lacal PM; Muzi A; Dorio AS; Leonetti C; Scarsella M; Ruffini F; Xu W; Min W; Stoppacciaro A; Colarossi C; Wang ZQ; Zhang J; Graziani G
Eur J Cancer; 2007 Sep; 43(14):2124-33. PubMed ID: 17714938
[TBL] [Abstract][Full Text] [Related]
5. Poly(ADP-ribose) polymerase-1 modulation of in vivo response of brain hypoxia-inducible factor-1 to hypoxia/reoxygenation is mediated by nitric oxide and factor inhibiting HIF.
Martínez-Romero R; Cañuelo A; Martínez-Lara E; Javier Oliver F; Cárdenas S; Siles E
J Neurochem; 2009 Oct; 111(1):150-9. PubMed ID: 19656264
[TBL] [Abstract][Full Text] [Related]
6. The properties of tumor-initiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor.
Xu XL; Xing BC; Han HB; Zhao W; Hu MH; Xu ZL; Li JY; Xie Y; Gu J; Wang Y; Zhang ZQ
Carcinogenesis; 2010 Feb; 31(2):167-74. PubMed ID: 19897602
[TBL] [Abstract][Full Text] [Related]
7. Poly(ADP-ribose) polymerase inhibition reduces tumor necrosis factor-induced inflammatory response in rheumatoid synovial fibroblasts.
García S; Bodaño A; Pablos JL; Gómez-Reino JJ; Conde C
Ann Rheum Dis; 2008 May; 67(5):631-7. PubMed ID: 17890271
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro.
Wang J; Zhao J; Chu ES; Mok MT; Go MY; Man K; Heuchel R; Lan HY; Chang Z; Sung JJ; Yu J
J Pathol; 2013 Aug; 230(4):441-52. PubMed ID: 23625826
[TBL] [Abstract][Full Text] [Related]
9. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
[TBL] [Abstract][Full Text] [Related]
10. The role of NF-κB in PARP-inhibitor-mediated sensitization and detoxification of arsenic trioxide in hepatocellular carcinoma cells.
Luo Q; Li Y; Lai Y; Zhang Z
J Toxicol Sci; 2015 Jun; 40(3):349-63. PubMed ID: 25972196
[TBL] [Abstract][Full Text] [Related]
11. GYY4137, a hydrogen sulfide (H₂S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway.
Lu S; Gao Y; Huang X; Wang X
Int J Oncol; 2014 Apr; 44(4):1259-67. PubMed ID: 24535538
[TBL] [Abstract][Full Text] [Related]
12. Small molecule inhibitors of Late SV40 Factor (LSF) abrogate hepatocellular carcinoma (HCC): Evaluation using an endogenous HCC model.
Rajasekaran D; Siddiq A; Willoughby JL; Biagi JM; Christadore LM; Yunes SA; Gredler R; Jariwala N; Robertson CL; Akiel MA; Shen XN; Subler MA; Windle JJ; Schaus SE; Fisher PB; Hansen U; Sarkar D
Oncotarget; 2015 Sep; 6(28):26266-77. PubMed ID: 26313006
[TBL] [Abstract][Full Text] [Related]
13. PJ34, an inhibitor of PARP-1, suppresses cell growth and enhances the suppressive effects of cisplatin in liver cancer cells.
Huang SH; Xiong M; Chen XP; Xiao ZY; Zhao YF; Huang ZY
Oncol Rep; 2008 Sep; 20(3):567-72. PubMed ID: 18695907
[TBL] [Abstract][Full Text] [Related]
14. Poly(ADP-ribose) polymerase-1 inhibitor modulates T regulatory and IL-17 cells in the prevention of adjuvant induced arthritis in mice model.
Ahmad SF; Zoheir KM; Bakheet SA; Ashour AE; Attia SM
Cytokine; 2014 Aug; 68(2):76-85. PubMed ID: 24845796
[TBL] [Abstract][Full Text] [Related]
15. Involvement of independent mechanism upon poly(ADP-ribose) polymerase (PARP) activation in methylmercury cytotoxicity in rat cerebellar granule cell culture.
Sakaue M; Mori N; Okazaki M; Ishii M; Inagaki Y; Iino Y; Miyahara K; Yamamoto M; Kumagai T; Hara S; Yamamoto M; Arishima K
J Neurosci Res; 2008 Nov; 86(15):3427-34. PubMed ID: 18627028
[TBL] [Abstract][Full Text] [Related]
16. PEDF effectively decreases VEGF to PEDF messenger RNA ratio of the inner edge of rat hepatocellular carcinoma induced by diethyl nitrosamine - an "in vivo" study.
Jeng KS; Sheen IS; Jeng WJ; Su JC
Hepatogastroenterology; 2012; 59(117):1484-90. PubMed ID: 22057317
[TBL] [Abstract][Full Text] [Related]
17. Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia.
Takahashi K; Pieper AA; Croul SE; Zhang J; Snyder SH; Greenberg JH
Brain Res; 1999 May; 829(1-2):46-54. PubMed ID: 10350529
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of arginine ADP-ribosyltransferase 1 reduces the expression of poly(ADP-ribose) polymerase-1 in colon carcinoma.
Tang Y; Wang YL; Yang L; Xu JX; Xiong W; Xiao M; Li M
Int J Mol Med; 2013 Jul; 32(1):130-6. PubMed ID: 23652727
[TBL] [Abstract][Full Text] [Related]
19. Neuropilin-1 modulates vascular endothelial growth factor-induced poly(ADP-ribose)-polymerase leading to reduced cerebrovascular apoptosis.
Mey L; Hörmann M; Schleicher N; Reuter P; Dönges S; Kinscherf R; Gassmann M; Gerriets T; Al-Fakhri N
Neurobiol Dis; 2013 Nov; 59():111-25. PubMed ID: 23816753
[TBL] [Abstract][Full Text] [Related]
20. PARP-1 inhibitors DPQ and PJ-34 negatively modulate proinflammatory commitment of human glioblastoma cells.
Scalia M; Satriano C; Greca R; Stella AM; Rizzarelli E; Spina-Purrello V
Neurochem Res; 2013 Jan; 38(1):50-8. PubMed ID: 23011206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
